Drug firms expected to defend huge price increases in House testimony

Drug manufacturers are due on Capitol Hill the morning of February 4 to answer questions about medication costs and sketchy practices designed to generate huge profits. Representatives from both Valeant Pharmaceuticals and Turing Pharmaceuticals are expected to appear before the House Committee on Oversight and Government Reform to try to justify recent spikes in the price of some drugs. According to prepared testimony, Valeant interim CEO Howard B.